Same medicine. Same results.
Lower cost.
  • Biosimilars

    Biosimilars

    GPhA applauds Congress for establishing an abbreviated...
  • Drug Shortages

    As members of the public who also are affected by...
  • Quality

    Science and quality are the cornerstones of the generic...
  • Patent Settlements

    Patent Settlements

    GPhA vigorously opposes restricting the right of parties in...
  • GDUFA

    GPhA and its member companies support full implementation...
 

Improving Lives for Less

*New data* The 2014 Generic Drug Savings in the U.S. report shows that generic pharmaceuticals saved the U.S. health system and patients $239 billion in 2013. That’s $1.46 trillion dollars in the most recent decade. This year's report discusses annual savings, 10-year savings and a breakdown by therapy area. All data were compiled by IMS Health on behalf of GPhA.   learn more >

Value and Quality

2013 Annual Report

The 2013 Annual Report is now available. GPhA furthers the industry’s goal to improve the lives of consumers by providing timely access to high quality, affordable medicine. Together, we continue to drive value and quality for patients. learn more >